Skip to NavigationSkip to content

Lophius Biosciences expands management team

Published on: 15/07/11

German biotech Lophius Biosciences has made six senior management appointments ahead of a planned 2012 market entry move.

The Regensburg-based company has appointed Sabine Wahlländer, Dr Hämmerle, Dr Karl Kleine, Dr Kornelia Schlombs, Dr Sascha Barabas and Dr Zanker.

Sabine joins as head of sales and marketing with more than 20 years of experience in the Life Science Industry. After working in several managerial positions with increasing responsibility in the pharmaceutical and medical products industry, she became general manager of Digene GmbH.

New head of technical operations Dr Hämmerle has more than 10 years’ managerial experience in biotech companies and was previously managing director at Meltec GmbH.

Dr Karl Kleine has been appointed head of quality management. He was heavily involved in the establishment of former Epidauros Biotechnologie AG as the world’s leading pharmacogenetic research organisation and after its takeover by Clinical Data Dr Kleine took on responsibility for worldwide quality management of Clinical Data´s genomic service subsidiary Cogenics.

Dr Kornelia Schlombs joins as scientific project manager for molecular biology. She has more than 12 years of experience in the biotechnology industry, including five years at Epidauros Biotechnologie.

Dr Sascha Barabas has been promoted to scientific project manager for cell biology and immunology. Since joining he has focused his efforts on product development of diagnostic test systems.

The new management team is completed by Dr Zanker, an experienced diagnostics regulatory affairs professional who joins from MedicalDevice+.

Dr Michael Lutz, chief executive of Lophius Biosciences, said: “We are delighted to have put together such an extremely experienced and effective team with these additional team members. Our current plans foresee to complete our first product development in the field of transplantation as CE-certified tests by the end of 2011.

Lophius Biosciences planned to introduce its new product in German-speaking markets from the beginning of 2012.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches